Table 3.
The diagnostic value of 18F-DCFPyL PET/CT for detecting lymph-node metastatic disease on a per-patient and template basis
| Patient-based accuracy | |||||
| pN1 | pN0 | Total | % (95%CI) | ||
| cN1 | 7 | 6 | 13 | 53.8 (26.1–79.6) | PPV |
| cN0 | 10 | 94 | 104 | 90.4 (82.6–95.0) | NPV |
| Total | 17 | 100 | 117 | 14.5 | Prevalence |
| % (95%CI) | 41.2 (19.4–66.5) | 94.0 (86.9–97.5) | |||
| Sensitivity | Specificity | ||||
| Template-based accuracy | |||||
| pN1 | pN0 | Total | % (95%CI) | ||
| cN1 | 8 | 10 | 18 | 44.4 (22.4–68.6) | PPV |
| cN0 | 15 | 435 | 450 | 96.6 (94.4–98.0) | NPV |
| Total | 23 | 445 | 468 | 4.9 | Prevalence |
| % (95%CI) | 34.7 (17.1–57.1) | 97.7 (95.7–98.9) | |||
| Sensitivity | Specificity | ||||
CI, confidence interval